BTIG analysts said today that MiniMed, the Medtronic diabetes business, has some significant pipeline updates.

Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared ...

Medtronic has landed on a new brand for the planned spinout of its diabetes division, and it didn’t have to look very far. | ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent ...

The American Diabetes Association’s annual conference kicks off amid a dynamic year for diabetes tech, as access improves for ...

Medtronic's diabetes care unit has grown faster than the rest of its business in recent years. Over the past few years, Medtronic (NYSE: MDT) has faced significant challenges, including a pandemic ...

Investors are increasingly eyeing the fast-growing MedSurg equipment space, which is projected to witness a compound annual growth rate (CAGR) of 9.54% from 2025 to 2030 (per Grand View Research). Two ...

Over the past few years, Medtronic (MDT 0.67%) has faced significant challenges, ... In the insulin pump niche, Medtronic has had to compete with companies such as Tandem Diabetes Care.

Last week, Medtronic announced the intent to separate its diabetes business into a new standalone company. The new company, which remains unnamed, is expected to launch within 18 months.

Medtronic’s decision to spin out its diabetes division into a separate entity marks a major shift — one that allows the medical device giant to shed a lower-margin, consumer-facing business ...